Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
PEGylation for improving the effectiveness of therapeutic biomoleculesGianfranco Pasut, Francesco M VeroneseDrug Discovery Today. Technologies|July 2, 2014
PEGylation: Posttranslational bioengineering of protein biotherapeuticsFrancesco M Veronese, Gianfranco PasutMethods in Molecular Biology (Clifton, N.J.)|June 16, 2004
Conjugates of peptides and proteins to polyethylene glycolsMargherita Morpurgo, Francesco M VeroneseAdvanced Drug Delivery Reviews|September 23, 2003
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugatesPaolo Caliceti, Francesco M VeroneseAdvanced Drug Delivery Reviews|August 13, 2009
PEG conjugates in clinical development or use as anticancer agents: an overviewGianfranco Pasut, Francesco M VeroneseJournal of Controlled Release : Official Journal of the Controlled Release Society|November 19, 2011
State of the art in PEGylation: the great versatility achieved after forty years of researchGianfranco Pasut, Francesco M VeroneseDrug Discovery Today|October 26, 2005
PEGylation, successful approach to drug deliveryFrancesco M Veronese, Gianfranco PasutBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 10, 2008
The impact of PEGylation on biological therapiesFrancesco M Veronese, Anna MeroAdvanced Drug Delivery Reviews|September 18, 2007
Anti-cancer PEG-enzymes: 30 years old, but still a current approachGianfranco Pasut, Mauro Sergi, Francesco M VeroneseAdvanced Drug Delivery Reviews|June 8, 2002
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitationFrancesco M Veronese, Paolo Caliceti, Oddone Schiavon, et al.Pageof 4